NCT00252135View on ClinicalTrials.gov

A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma

CompletedOBSERVATIONAL
Enrollment

8,023

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Asthma
Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY